These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35742177)

  • 1. Antibiotic Resistance of
    Le LTT; Nguyen TA; Nguyen NA; Nguyen YTH; Nguyen HTB; Nguyen LT; Vi MT; Nguyen T
    Healthcare (Basel); 2022 Jun; 10(6):. PubMed ID: 35742177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Resistance of
    Vu TB; Tran TNQ; Tran TQA; Vu DL; Hoang VT
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676631
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Le LTT; Nguyen TA; Nguyen NA; Nguyen YTH; Nguyen HTB; Nguyen LT; Vi MT; Nguyen T
    Children (Basel); 2022 Jul; 9(7):. PubMed ID: 35884002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Primary Antibiotic Resistance of
    Krzyżek P; Pawełka D; Iwańczak B; Kempiński R; Leśniakowski K; Mégraud F; Łaczmański Ł; Biernat M; Gościniak G
    Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32370201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
    Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
    J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.
    Huang X; Liu Y; Lin Z; Wu B; Nong G; Chen Y; Lu Y; Ji X; Zhou X; Suo B; Chen Q; Wei J
    PLoS One; 2021; 16(9):e0256225. PubMed ID: 34473713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Resistance of
    Li J; Deng J; Wang Z; Li H; Wan C
    Front Microbiol; 2020; 11():621791. PubMed ID: 33574804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
    Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori Multidrug Resistance Due to Misuse of Antibiotics in Iran.
    Saniee P; Hosseini F; Kadkhodaei S; Siavoshi F; Khalili-Samani S
    Arch Iran Med; 2018 Jul; 21(7):283-288. PubMed ID: 30041525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.
    Shu X; Ye D; Hu C; Peng K; Zhao H; Li H; Jiang M
    Sci Rep; 2022 Oct; 12(1):17754. PubMed ID: 36272980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potential of Sitafloxacin as a New Drug Candidate for
    Choi YI; Lee SM; Chung JW; Kim KO; Kwon KA; Kim YJ; Kim JH; Lee SM; Jeong JY; Park DK
    Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.
    Dang NQH; Ha TMT; Nguyen ST; Le NDK; Nguyen TMT; Nguyen TH; Pham TTH; Tran VH
    J Glob Antimicrob Resist; 2020 Sep; 22():620-624. PubMed ID: 32590188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
    Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
    Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antibiotic resistance of
    Tang X; Chen X; Shen Y; Yang T; Hu R; Debowski AW; Stubbs KA; Benghezal M; Marshall BJ; Li H; Tang H
    Future Microbiol; 2020 Sep; 15():1353-1361. PubMed ID: 32900223
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
    Lu HH; Lai FP; Lo HY; Sheu BS; Yang YJ
    Helicobacter; 2019 Oct; 24(5):e12633. PubMed ID: 31295754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
    Makobongo MO; Einck L; Peek RM; Merrell DS
    PLoS One; 2013; 8(7):e68917. PubMed ID: 23935905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
    Yakoob J; Abid S; Abbas Z; Jafri SN
    Br J Biomed Sci; 2010; 67(4):197-201. PubMed ID: 21294447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Fluoroquinolone Resistant Strains of Helicobacter pylori in the Golden triangle.
    Vilaichone RK; Ratanachu ek T; Gamnarai P; Subsomwong P; Uchida T; Yamaoka Y; Mahachai V
    Asian Pac J Cancer Prev; 2017 Feb; 18(2):455-458. PubMed ID: 28345829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori.
    Siavoshi F; Saniee P; Malekzadeh R
    Helicobacter; 2018 Dec; 23(6):e12531. PubMed ID: 30230637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
    Kim JY; Kim N; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Nam RH; Kim JM; Lee JH; Jung HC; Song IS
    Korean J Gastroenterol; 2011 Dec; 58(2):74-81. PubMed ID: 21873821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.